Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Andrew Gregory Health editor

Prostate cancer drug that can halve death risk to be offered to thousands in England

Medic in scrubs and gloves holding a patient chart
Prostate Cancer UK said there were concerns some eligible men may still be unable to access the drug because of a ‘postcode lottery of care’ in England. Photograph: Alamy

Thousands of men with advanced prostate cancer in England are to be offered a drug that can halve the risk of death.

In guidance published on Friday, the National Institute for Health and Care Excellence (Nice) gave the green light to darolutamide, which attacks the disease by starving cancer cells and has fewer side-effects than existing treatments.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.